Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 53,418 | 60,293 | 71,404 | 76,814 | 36,532 |
| Marketable Securities | N/A | N/A | N/A | N/A | 34,985 |
| Receivables | 52,341 | 41,321 | 30,126 | 15,496 | 17,727 |
| Inventories | 25,815 | 16,411 | 13,171 | 10,400 | 8,922 |
| TOTAL | $137,215 | $131,028 | $123,819 | $107,322 | $103,268 |
| Non-Current Assets | |||||
| PPE Net | 50,778 | 41,607 | 41,119 | 39,136 | 38,713 |
| Other Non-Current Assets | 5,447 | 4,530 | 4,065 | 4,101 | 4,385 |
| TOTAL | $56,225 | $46,137 | $45,184 | $43,237 | $43,098 |
| Total Assets | $193,440 | $177,165 | $169,003 | $150,559 | $146,366 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 28,834 | 25,865 | 21,926 | 16,178 | 15,175 |
| Accrued Expenses | 32,256 | 22,393 | 36,745 | 28,246 | 25,269 |
| Other current liabilities | 1,854 | 1,836 | 1,818 | 1,439 | 1,384 |
| TOTAL | $81,854 | $57,762 | $66,443 | $47,861 | $47,496 |
| Non-Current Liabilities | |||||
| Long Term Debt | 110,000 | 90,000 | 60,000 | 30,000 | N/A |
| Deferred Revenues | 18,910 | 7,668 | 5,954 | 1,998 | 5,668 |
| Other Non-Current Liabilities | 10,122 | 10,507 | 10,892 | 9,261 | 9,354 |
| TOTAL | $120,122 | $100,507 | $70,892 | $39,261 | $9,354 |
| Total Liabilities | $201,976 | $158,269 | $137,335 | $87,122 | $56,850 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,240 | 37,038 | 36,882 | 36,253 | 36,022 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -558,851 | -525,472 | -506,349 | -468,238 | -435,594 |
| Other shareholders' equity | -200 | -177 | 109 | 78 | 65 |
| TOTAL | $-8,536 | $18,896 | $31,668 | $63,437 | $89,516 |
| Total Liabilities And Equity | $193,440 | $177,165 | $169,003 | $150,559 | $146,366 |